Vanguard Personalized Indexing Management, LLC Kezar Life Sciences, Inc. Transaction History

Vanguard Personalized Indexing Management, LLC

$6.09 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 12, 2024	BUY	$0.6 - $0.92 $7,564 - $11,599	12,608 New	12,608 $7,000
Q3 2023 Nov 08, 2023	BUY	$1.08 - $2.54 $14,495 - $34,091	13,422 New	13,422 $15,000

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

Suvretta Capital Management, LLC New York, NY

7.17M
Shares

$46.7 Million
0.22% of portfolio
Avidity Partners Management LP Dallas, TX

5.03M
Shares

$32.8 Million
0.24% of portfolio
Tang Capital Management LLC San Diego, CA

3.64M
Shares

$23.7 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.74M
Shares

$17.9 Million
0.0% of portfolio
Affinity Asset Advisors, LLC New York, NY

2.51M
Shares

$16.4 Million
0.33% of portfolio

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Account